Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.
The ESC is involved in a number of EU funded research projects, often as a dissemination partner. Our role is fundamental to ensure the very latest scientific best practice is shared with as many cardiovascular practitioners, researchers and institutions as possible.
European Sudden Cardiac Arrest network: towards Prevention, Education and NEw Treatment
Start date: January 2017
End date: December 2022
Beta3_LVH
A multi-center randomized, placebo-controlled trial of mirabegron, a new beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease
Start date: May 2015
End date: August 2022
Our mission: To reduce the burden of cardiovascular disease.
Our mission: To reduce the burden of cardiovascular disease.